Mechanisms of action of mycophenolate mofetil in preventing chronic rejection.
Allison
A C
AC
SurroMed Corporation, Mountain View, California 94043, USA. aallison@surromed.com
D002455:Cell Division / Q000187:drug effects; D002908:Chronic Disease; D003586:Cytomegalovirus Infections / Q000517:prevention & control; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007518:Isoantibodies / Q000097:blood; D009131:Muscle, Smooth, Vascular / Q000166:cytology; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D007518:Isoantibodies; D009173:Mycophenolic Acid